Roivant Sciences Insider Sold Shares Worth $8,449,810, According to a Recent SEC Filing
Matthew Gline, Director, Chief Executive Officer, on April 16, 2026, sold 289,774 shares in Roivant Sciences (ROIV) for $8,449,810. Following the Form 4 filing with the SEC, Gline has control over a total of 16,736,116 common shares of the company, with 16,736,116 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1635088/000163508826000038/xslF345X05/wk-form4_1776724041.xml